A large number of drug manufacturers are failing to complete the FDA’s Accelerated Approval Program, meaning not all available drugs are fully approved, finds a study.
The U.S. Food and Drug Administration (FDA) today is extending the indication of Ibrance (palbociclib) capsules in combination with specific endocrine therapies...
One of the most common congenital heart defects occurring in premature babies, PDA is a potentially life-threatening opening between two blood vessels leading from the heart